Details for New Drug Application (NDA): 090999
✉ Email this page to a colleague
NDA 090999 describes APREPITANT, which is a drug marketed by Glenmark Speclt, Sandoz, Torrent, Azurity, and Mylan, and is included in five NDAs. It is available from five suppliers. Additional details are available on the APREPITANT profile page.
The generic ingredient in APREPITANT is aprepitant. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the aprepitant profile page.
The generic ingredient in APREPITANT is aprepitant. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the aprepitant profile page.
Summary for 090999
| Tradename: | APREPITANT |
| Applicant: | Sandoz |
| Ingredient: | aprepitant |
| Patents: | 0 |
Suppliers and Packaging for NDA: 090999
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| APREPITANT | aprepitant | CAPSULE;ORAL | 090999 | ANDA | Sandoz Inc | 0781-2321 | 0781-2321-06 | 1 BLISTER PACK in 1 CARTON (0781-2321-06) / 1 CAPSULE in 1 BLISTER PACK |
| APREPITANT | aprepitant | CAPSULE;ORAL | 090999 | ANDA | Sandoz Inc | 0781-2321 | 0781-2321-51 | 5 BLISTER PACK in 1 CARTON (0781-2321-51) / 1 CAPSULE in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 40MG | ||||
| Approval Date: | Sep 24, 2012 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 80MG | ||||
| Approval Date: | Sep 24, 2012 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 125MG | ||||
| Approval Date: | Sep 24, 2012 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
